| Pharmacogenomics in chronic pain therapy: from disease to treatment and challenges for clinical practice PA Yamamoto, AC Conchon Costa, GR Lauretti, NV De Moraes Pharmacogenomics 20 (13), 971-982, 2019 | 19 | 2019 |
| Pharmacogenetics‐based population pharmacokinetic analysis of gabapentin in patients with chronic pain: Effect of OCT 2 and OCTN 1 gene polymorphisms PA Yamamoto, JRL Benzi, FJ Azeredo, F Dach, E Ianhez Júnior, ... Basic & Clinical Pharmacology & Toxicology 124 (3), 266-272, 2019 | 14* | 2019 |
| Cetirizine reduces gabapentin plasma concentrations and effect: role of renal drug transporters for organic cations ACC Costa, PA Yamamoto, GR Lauretti, JR de Lima Benzi, CF Zanelli, ... The Journal of Clinical Pharmacology 60 (8), 1076-1086, 2020 | 11 | 2020 |
| Mapping surface residues of eIF5A that are important for binding to the ribosome using alanine scanning mutagenesis NM Barbosa, PEG Boldrin, D Rossi, PA Yamamoto, TF Watanabe, ... Amino acids 48, 2363-2374, 2016 | 9 | 2016 |
| Population pharmacokinetics of gabapentin in patients with neuropathic pain: Lack of effect of diabetes or glycaemic control ACC Costa, JR de Lima Benzi, PA Yamamoto, MCF de Freitas, ... British Journal of Clinical Pharmacology 87 (4), 1981-1989, 2021 | 7 | 2021 |
| The role of organic cation transporter 2 inhibitor cimetidine, experimental diabetes mellitus and metformin on gabapentin pharmacokinetics in rats JR de Lima Benzi, PA Yamamoto, JH Stevens, AM Baviera, ... Life sciences 200, 63-68, 2018 | 7 | 2018 |
| Chemometric optimization of salting-out assisted liquid–liquid extraction (SALLE) combined with LC-MS/MS for the analysis of carvedilol enantiomers in human plasma: application … M Pavan, P Yamamoto, RM Da Silva, WS Junior, J Dos Santos, R Kemp, ... Journal of Chromatography B 1205, 123338, 2022 | 6 | 2022 |
| Pharmacokinetics of carboplatin in combination with low-dose cyclophosphamide in female dogs with mammary carcinoma MC Machado, PA Yamamoto, LF Pippa, NV de Moraes, FMF Neves, ... Animals 12 (22), 3109, 2022 | 4 | 2022 |
| Therapeutic drug monitoring of gabapentin: the applicability in patients with neuropathic pain PA Yamamoto, JRL Benzi, F Dach, NV Moraes Brazilian Journal of Pharmaceutical Sciences 58, e191073, 2022 | 3 | 2022 |
| Análise simultânea dos indicadores biológicos de exposição aos solventes etilbenzeno, estireno, tolueno e xileno na urina por CLAE-UV PA Yamamoto, NV Moraes, VP Silva, JS Lepera Química Nova 39, 1131-1135, 2016 | 3 | 2016 |
| Metabolism Characterization and Chemical and Plasma Stability of Casearin B and Caseargrewiin F FB Oda, FA Carvalho, PA Yamamoto, JA de Oliveira, RG Peccinini, ... Planta Medica 89 (11), 1097-1105, 2023 | 2 | 2023 |
| A pilot study of chemotherapy combinations in rats: Focus on mammary cancer treatment in female dogs LP Silva, PA Yamamoto, MC de Araújo Machado, FMF Neves, FJ Azeredo, ... Research in Veterinary Science 156, 14-21, 2023 | 1 | 2023 |
| Simple and rapid HPLC-UV methods for gabapentin quantification in human plasma and urine: applicability in pharmacokinetics and drug monitoring PA Yamamoto, JR de Lima Benzi, NV de Moraes Revista de Ciências Farmacêuticas Básica e Aplicada 42, 1-11, 2021 | 1 | 2021 |
| Effect of Roux‐En‐Y Gastric Bypass in the Pharmacokinetics of (R)‐Carvedilol and (S)‐Carvedilol PA Yamamoto, R Cristofoletti, V Vozmediano, CM de Gaitani, RM da Silva, ... The Journal of Clinical Pharmacology 63 (7), 838-847, 2023 | | 2023 |
| Carvedilol pharmacokinetics and PBPK modeling in obesity and post-Roux-en-Y gastric bypass patients P Yamamoto, W Salgado Jr, J dos Santos, R Kemp, A Sankarankutty, ... EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 78 (SUPPL 1), S112-S112, 2022 | | 2022 |
| Population pharmacokinetics of gabapentin in patients with neuropathic pain: the role of glycaemic control AC Costa, JR Benzi, P Yamamoto, MC Foss-Freitas, FJ de Paula, ... Authorea Preprints, 2020 | | 2020 |
| BASIC & CLINICAL PA Yamamoto, JRL Benzi, FJ Azeredo, F Dach, EI Júnior, CF Zanelli | | 2019 |
| Gabapentin pharmacokinetics and renal excretion: the role of glycemic control and the drug transporters hOCTs, hOCTN1 and hMATEs AC Costa, PA Yamamoto, J Benzi, GR Lauretti, G Ciarimboli, ... Galoá, 2019 | | 2019 |
| Impact of diabetes on gabapentin pharmacokinetics in patients with neuropathic pain ACC Costa, PA Yamamoto, J Benzi, GR Lauretti, NV de Moraes Toxicology Letters 295, S95, 2018 | | 2018 |
| Impacto dos polimorfismos genéticos de OCT2 e OCTN1 na disposição cinética da gabapentina em pacientes com dor crônica PA Yamamoto Universidade Estadual Paulista (Unesp), 2018 | | 2018 |
